BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Matsuoka T, Yashiro M. Molecular-targeted therapy toward precision medicine for gastrointestinal cancer: Current progress and challenges. World J Gastrointest Oncol 2021; 13(5): 366-390 [PMID: 34040699 DOI: 10.4251/wjgo.v13.i5.366]
URL: https://www.wjgnet.com/2307-8960/full/v13/i5/366.htm
Number Citing Articles
1
Qianqian Wang, Chao Huang, Ying Ding, Shaodi Wen, Xin Wang, Shuwei Guo, Qiuzhi Gao, Zhihong Chen, Yuanyuan Zhao, Mei Wang, Bo Shen, Wei Zhu. Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem CellsFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.884373
2
Ming Li, Ou Cai, Yuanjie Yu, Shiyun Tan. Paeonol inhibits the malignancy of Apatinib-resistant gastric cancer cells via LINC00665/miR-665/MAPK1 axisPhytomedicine 2022; 96: 153903 doi: 10.1016/j.phymed.2021.153903
3
Siddharth Menon, Sagun Parakh, Andrew M. Scott, Hui K. Gan. Antibody-drug conjugates: beyond current approvals and potential future strategiesExploration of Targeted Anti-tumor Therapy 2022; : 252 doi: 10.37349/etat.2022.00082
4
Fei Jiang, Guangxi Liu, Xiaowei Chen, Qiong Li, Fujin Fang, Xiaobing Shen. Hsa_circ_0044301 Regulates Gastric Cancer Cell’s Proliferation, Migration, and Invasion by Modulating the Hsa-miR-188-5p/DAXX Axis and MAPK PathwayCancers 2022; 14(17): 4183 doi: 10.3390/cancers14174183